# OnCo record nct06852222 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06852222/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06852222", "NCT06852222" ;
  schema:name "A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)"@en ;
  schema:alternateName "cAMeLot-2"@en ;
  schema:description "A phase 3 trial testing Bleximenib in acute myeloid leukaemia, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06852222/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06852222> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-06-04" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-npm1-kmt2a/>, <https://onco.cc/cancers/aml-older-unfit/> ;
  onco:drugs <https://onco.cc/drugs/bleximenib/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> .